BMS backs Stand Up To Cancer lung research

Share this article:

Bristol-Myers Squibb is kicking in $5 million to support a new lung cancer research “Dream Team.” The money is going toward a new collaboration between the American Cancer Society and the group Stand Up To Cancer.

The BMS contribution covers 20% of the Dream Team's three-year research budget.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.